EA200200232A1 - Интерлейкин-5 ингибирующие производные 6-азаурацила - Google Patents

Интерлейкин-5 ингибирующие производные 6-азаурацила

Info

Publication number
EA200200232A1
EA200200232A1 EA200200232A EA200200232A EA200200232A1 EA 200200232 A1 EA200200232 A1 EA 200200232A1 EA 200200232 A EA200200232 A EA 200200232A EA 200200232 A EA200200232 A EA 200200232A EA 200200232 A1 EA200200232 A1 EA 200200232A1
Authority
EA
Eurasian Patent Office
Prior art keywords
derivatives
azauracil
inhibitive
interleukin
methods
Prior art date
Application number
EA200200232A
Other languages
English (en)
Other versions
EA004740B1 (ru
Inventor
Жан Фернан Арман Лякрамп
Эдди Жан Эдгар Фрейн
Фредерик Дирк Дерос
Жером Мишель Клод Фортэн
Эрвин Кусеманс
Original Assignee
Янссен Фармацевтика Н.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Янссен Фармацевтика Н.В. filed Critical Янссен Фармацевтика Н.В.
Publication of EA200200232A1 publication Critical patent/EA200200232A1/ru
Publication of EA004740B1 publication Critical patent/EA004740B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0461—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0463—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0468—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Abstract

Настоящее изобретение относится к ингибирующим ИЛ-5 (IL-5) производным 6-азаурацила формулы (I), пригодным для лечения эозинофилзависимых воспалительных заболеваний, к способам и промежуточным соединениям для их получения и к фармацевтическим композициям, содержащим указанные производные. Кроме того, настоящее изобретение относится к применению указанных производных в качестве лекарственного средства и к способам маркировки рецептора или визуализации органа с использованием указанных производных.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200200232A 1999-08-06 2000-07-31 Интерлейкин-5 ингибирующие производные 6-азаурацила EA004740B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99870170 1999-08-06
EP99126035 1999-12-27
PCT/EP2000/007358 WO2001010866A1 (en) 1999-08-06 2000-07-31 Interleukin-5 inhibiting 6-azauracil derivatives

Publications (2)

Publication Number Publication Date
EA200200232A1 true EA200200232A1 (ru) 2002-08-29
EA004740B1 EA004740B1 (ru) 2004-08-26

Family

ID=26153219

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200200232A EA004740B1 (ru) 1999-08-06 2000-07-31 Интерлейкин-5 ингибирующие производные 6-азаурацила

Country Status (30)

Country Link
US (1) US6911444B2 (ru)
EP (1) EP1206471B1 (ru)
JP (1) JP2003506451A (ru)
KR (1) KR100795484B1 (ru)
CN (1) CN1188410C (ru)
AR (1) AR025046A1 (ru)
AT (1) ATE318811T1 (ru)
AU (1) AU780047B2 (ru)
BG (1) BG106367A (ru)
BR (1) BR0013014A (ru)
CA (1) CA2380759A1 (ru)
CO (1) CO5050264A1 (ru)
CZ (1) CZ2002356A3 (ru)
DE (1) DE60026312T2 (ru)
EA (1) EA004740B1 (ru)
EE (1) EE200200057A (ru)
ES (1) ES2260031T3 (ru)
HK (1) HK1048634B (ru)
HR (1) HRP20020096A2 (ru)
HU (1) HUP0202692A3 (ru)
IL (1) IL147976A0 (ru)
MX (1) MXPA02001343A (ru)
MY (1) MY133512A (ru)
NO (1) NO322386B1 (ru)
NZ (1) NZ516506A (ru)
PL (1) PL353475A1 (ru)
SK (1) SK1642002A3 (ru)
TR (1) TR200200310T2 (ru)
TW (1) TWI271404B (ru)
WO (1) WO2001010866A1 (ru)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6818787B2 (en) 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
WO2003072554A1 (en) * 2002-02-28 2003-09-04 Takeda Chemical Industries, Ltd. Azole compounds
JP2008503447A (ja) * 2004-05-29 2008-02-07 ７ティーエム ファーマ エイ／エス Ｃｒｔｈ２リガンドとしての置換チアゾール酢酸
WO2010027762A1 (en) 2008-09-04 2010-03-11 Boehringer Ingelheim International Gmbh Indolizine inhibitors of leukotriene production
JP4743340B1 (ja) * 2009-10-28 2011-08-10 セントラル硝子株式会社 保護膜形成用薬液
EP2509975B1 (en) 2009-12-04 2014-04-23 Boehringer Ingelheim International GmbH Benzimidazole inhibitors of leukotriene production
SG187549A1 (en) 2010-08-16 2013-03-28 Boehringer Ingelheim Int Oxadiazole inhibitors of leukotriene production
WO2012027322A1 (en) 2010-08-26 2012-03-01 Boehringer Ingelheim International Gmbh Oxadiazole inhibitors of leukotriene production
WO2012040139A1 (en) 2010-09-23 2012-03-29 Boehringer Ingelheim International Gmbh Oxadiazole inhibitors of leukotriene production
JP5828188B2 (ja) * 2010-09-23 2015-12-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ロイコトリエン産生のオキサジアゾール阻害剤
EP2632915B1 (en) 2010-10-29 2015-08-12 Boehringer Ingelheim International GmbH Benzimidazole inhibitors of leukotriene production
WO2012061169A1 (en) 2010-11-01 2012-05-10 Boehringer Ingelheim International Gmbh Benzimidazole inhibitors of leukotriene production
EP2651930B1 (en) 2010-12-16 2015-10-28 Boehringer Ingelheim International GmbH Biarylamide inhibitors of leukotriene production
AR089853A1 (es) 2012-02-01 2014-09-24 Boehringer Ingelheim Int Inhibidores de oxadiazol de la produccion de leucotrienos para terapia de combinacion, composicion farmaceutica, uso

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US42416A (en) * 1864-04-19 Improvement in harvesters
US10177A (en) * 1853-11-01 Improved pen and pencil case
FR2476087A1 (fr) * 1980-02-18 1981-08-21 Roussel Uclaf Nouvelles oximes derivees de l'acide 3-alkyloxy ou 3-alkyl-thiomethyl 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
CA1244024A (en) 1984-08-01 1988-11-01 Gustaaf M. Boeckx .alpha.- ARYL-4-(4,5-DIHYDRO-3,5-DIOXO-1,2,4-TRIAZIN- 2(3H)-YL)BENZENEACETONITRILES
US4631278A (en) 1984-08-01 1986-12-23 Janssen Pharmaceutica N.V. Anti-protozoal α-aryl-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)-benzeneacetonitrile derivatives, pharmaceutical compositions, and method of use therefor
GB8602342D0 (en) 1986-01-30 1986-03-05 Janssen Pharmaceutica Nv 5 6-dihydro-2-(substituted phenyl)-1 2 4-triazine-3 5(2h 4h)-diones
KR20010014049A (ko) * 1997-07-10 2001-02-26 디르크 반테 Ｉｌ-5를 저해하는 6-아자우라실 유도체
PL337875A1 (en) * 1997-07-10 2000-09-11 Janssen Pharmaceutica Nv Derivatives of 6-azauracil as il-5 inhibitors
EP0987265A1 (en) 1998-09-18 2000-03-22 Janssen Pharmaceutica N.V. Interleukin-5 inhibiting 6-azauracil derivatives

Also Published As

Publication number Publication date
HUP0202692A3 (en) 2003-01-28
EP1206471B1 (en) 2006-03-01
TWI271404B (en) 2007-01-21
SK1642002A3 (en) 2003-03-04
MXPA02001343A (es) 2002-07-22
CN1368972A (zh) 2002-09-11
NO20020565L (no) 2002-03-26
AR025046A1 (es) 2002-11-06
JP2003506451A (ja) 2003-02-18
HUP0202692A2 (hu) 2002-12-28
AU780047B2 (en) 2005-02-24
KR20020012317A (ko) 2002-02-15
DE60026312D1 (de) 2006-04-27
NO322386B1 (no) 2006-09-25
CN1188410C (zh) 2005-02-09
AU6160900A (en) 2001-03-05
MY133512A (en) 2007-11-30
HK1048634A1 (en) 2003-04-11
CA2380759A1 (en) 2001-02-15
NZ516506A (en) 2004-02-27
US6911444B2 (en) 2005-06-28
EE200200057A (et) 2003-04-15
EA004740B1 (ru) 2004-08-26
KR100795484B1 (ko) 2008-01-16
WO2001010866A1 (en) 2001-02-15
HK1048634B (zh) 2005-09-30
IL147976A0 (en) 2002-09-12
EP1206471A1 (en) 2002-05-22
ES2260031T3 (es) 2006-11-01
BG106367A (bg) 2002-09-30
CO5050264A1 (es) 2001-06-27
NO20020565D0 (no) 2002-02-05
DE60026312T2 (de) 2006-12-21
BR0013014A (pt) 2002-04-16
CZ2002356A3 (cs) 2002-06-12
ATE318811T1 (de) 2006-03-15
TR200200310T2 (tr) 2002-08-21
US20030114453A1 (en) 2003-06-19
PL353475A1 (en) 2003-11-17
HRP20020096A2 (en) 2005-10-31

Similar Documents

Publication Publication Date Title
EA200200232A1 (ru) Интерлейкин-5 ингибирующие производные 6-азаурацила
BRPI0510623A (pt) compostos de derivados de prolina e morfolina
EA200201271A1 (ru) Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1
BRPI0406801B8 (pt) derivados de tieno-pirimidinodiona e uso dos mesmos na modulação de doenças autoimunes
AR102722A2 (es) Un derivado de pirazolo-quinazolina, su uso, un procedimiento para prepararlos, composiciones farmacéuticas que los comprenden, compuestos utilizables en su preparación, una biblioteca de dos o más compuestos, y un producto o kit
PT1404347E (pt) Nucleosidos 4'-substituidos para o tratamento de doencas mediadas pelo virus da hepatite c
EA200200360A1 (ru) Производные пурина
AR029383A1 (es) Moleculas pequenas, los intermediarios para su sintesis, las composiciones farmaceuticas que las contienen y su uso para preparar un medicamento destinado al tratamiento o la profilaxis de enfermedades inflamatorias o mediadas por celulas inmunes
ES2162676T3 (es) Derivados de fenileno sustituidos en meta y su uso como antagonistas o inhibidores de integrina alfav,beta3.
ATE327977T1 (de) Tetrahydrochinolin-derivate als crth2 antagonisten
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
BRPI0108395B8 (pt) derivados de pirrolopirimidinona, processos de preparação e uso
ATE253545T1 (de) Biarylessigsäure-derivate und ihre verwendung als cox-2 inhibitoren
EA200870302A1 (ru) 1,3-диоксанкарбоновые кислоты
FR2903107B1 (fr) Derives d'imidazopyridine-2-carboxamides, leur preparation et leur application en therapeutique
EA200500377A1 (ru) Пиразольные производные как ингибиторы трансформирующего фактора роста (tgf)
TN2009000483A1 (fr) Derives de 7-alkynyl-1-8-naphthyridones, leur preparation et leur application en therapeutique
FR2361901A1 (fr) Derives de substitution de nucleotides et medicament contenant ces substances
SE9904421D0 (sv) New compounds
EA200200108A1 (ru) Производные стрептограминов, способ их получения и композиции на их основе
TR200000153T2 (tr) İl-5 inhibite eden 6-azaurasil türevleri.
EA200101241A1 (ru) Производные индола
HUP0402602A2 (hu) Eljárás echinokandin-származékok előállítására, ezek alkalmazása, ezeket tartalmazó gyógyszerkészítmények és intermedierek
DE69814473D1 (de) Neue allythiopyridazinderivate und verfahren zu ihrer herstellung
NO20055754L (no) Kolkisosidanaloger

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU